ArticleLancet (London, England)2025

Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series.

Neil A Shneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.